Premenstrual dysphoric disorder (PMDD) with symptoms such as irritability, sadness, and anxiety in the days leading up to her menstrual period, is severe than premenstrual syndrome (PMS) which is much more common.
The findings showed that women with PMDD are more sensitive to the effects of sex hormones estrongen and progesterone, due to a molecular mechanism in their genes.
The study proves “that PMDD is a disorder of cellular response to estrogen and progesterone”, said Peter Schmidt from the NIH’s National Institute of Mental Health, Behavioral Endocrinology Branch.
The researchers revealed that turning off estrogen and progesterone eliminated PMDD symptoms, while re-introducing the hormones triggered the re-emergence of symptoms.
This confirmed that they had a biologically-based behavioural sensitivity to the hormones that might be reflected in molecular differences detectable in their cells.
“This is a big moment for women’s health, because it establishes that women with PMDD have an intrinsic difference in their molecular apparatus for response to sex hormones — not just emotional behaviours they should be able to voluntarily control,” added David Goldman from the NIH’s National Institute on Alcohol Abuse and Alcoholism.
The study may also help improve treatment of such prevalent reproductive endocrine-related mood disorders.
For the study, published in the journal Molecular Psychiatry, the researchers studied how gene expression was controlled in white blood cells from women with PMDD and controls.
They found a complex of genes that acts differently in women with the disorder compared to women without it.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022